Advances in spray drying technology: New applications for a proven process

American Pharmaceutical Review

Volumn 11, Issue 1, 2008, Pages

  Parikh, Dilip M ^a  

^a DPharma Group Inc

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC SOLVENT;

DISPERSION; DRUG DOSAGE FORM; MICROENCAPSULATION; NEBULIZER; PARTICLE SIZE; REVIEW; SPRAY DRYING; TABLET COMPRESSION;

EID: 55949117616     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kostewicz, E.S. et.al. "Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine", J. Pham. Pharmcol, 56, 43-51, (2004).
2. Morris,KR, Griesserb UJ, Eckhardt CJ, Stowell JG "Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes" Adv. Drug Deliv. Res., 48 (2001) 91-114.
3. Matsumoto N, Kaneniwa N, Higuchi S, Otsuka M. " Effects of temperature and pressure during compression on the polymorphic transformation and crushing strength of chlorpropamide tabltes" J. Pharma. Pharmacol, 43 (1991) pp 74-78.
4. Otsuka M, Nakanishi M, Matsuda Y. "Effects of crystalline form on compression mechanism of phenobarbital polymorphs" Drug Dev. Ind. Phram. 25 (1999)pp 835-842.
5. Lefebvre C, Guyot-Hermann AM, Draguet-Bruchmans M, Bouche R. "Polymorphic transitions of carbamazepine during grinding and compression", Drug Dev. Ind. Pharm. 12(1986) pp 1913-1927.
6. Shamblin SL, Huang EY, Zografi G "The effect of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose" Journal of Thermal Analysis 47(5): 1567-1579 (1996).
7. Beggren J, et.al. "Effect of polymer content and molecular weight on the morphology and heat and moisture induced transformations of spray-dried composite particles of amorphous lactose and poly(vinylpyrrolidine)" Pharmaceutical Research 20(7): 1039-1046 (2003).
8. Takeuchi H, Yasuji T, Yamamoto H, Kawashima Y, " Temperature induced crystallization and compactability of spray dried composite particles composed of amorphous lactose and various types of water soluble polymer." Chemical and Pharma. Bulletin 48 (4) 2000, pp 585-588.
9. Matsumoto T, Zografi G, " Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidine) and poly(vinylpryrrolidine- co-vinylacetate) in relation to indomethacine crystallization" Pharmaceutical Research 16(11) 1999, pp 1722-1728.
10. Aso Y, Yoshioka s, Kojima s, "Molecular mobility based estimation of the crystallization rates of amorphous nifedipine and Phenobarbital in poly(vinylprrolidine)solid dispersions. "J. of Pharm Sci. 93(2), 2004, PP384-391.
11. Hancock BC, Shamblin SL, Zografi G, "Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperature" Pharm. Research, 12(6) 1995, pp799-806.
12. Chauhan B, Shimpi S, Paradkar A. " Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique" European J. Pharm. Sc., 26 (2005)pp 219-230.
13. ShimpiSL,ChauhanB, MahadikKR,Paradkar AR, "Stabilization and improved in-vivo performance of amorphous etoricoxib using gelucire 50/13," Pharm.Res. 22 (2005) pp1727-1734.
14. Dhumal RS, Shimpi SL, Paradkar AR. "Development of spray dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers" Acta. Pharm. 57 (2007) pp 287-300.
15. Weuts I, Kempen D, Decorte A,VerreckG, Peeters J, Brewster M, Van den Mooter G. " Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with polymers PVPK30 and PVP-VA64" Eur.J.Pharm. Sc. 25 (2005) pp313-320.
16. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. "Physical stabilization of anhydrous ketoconazol in solid dispersions with polyvinylpyrrolidine. Eur. J. Pharm.Sc. 12 (2001) pp 261-269
17. Weuts I, Kempen D, Verreck G, Peeters J, Brewster M, Blaton N, Van den Mooter G. " Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage" European .J. Pharm. Sc. 25 (2005) 387-393.
18. Jung J, Yoo S, Lee S, Kim K, Yoon D, Lee K. " Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique" Int. J. Pharmaceutics, 187 (1999) pp 209-218.
19. Ohta M, Buckton G. "A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities" Int. J. Pharmaceutics, 289(2005) pp31-38.
20. Hadinoto K, Zhu K, Tan RBH. "Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery" Int. J. Pharmaceutics 341 (2007) 195-206.
21. Grenha A, Seijo B, Remunan-Lopez C. "Microencapsulted chitosan nanoparticles for lung protein delivery Euro. J. Pharm. Sc. 25 (2005) pp 427-437.
22. Maa YF, Nguyen PA, AndyaJ D, Dasovich N, Sweent TD, Shire SJ, Hsu CC. "Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders "Pharm. Res. 15 (1998) pp768-775.
23. Candy SM, Steber WD, Fishbein R. "Porcess International Symp. Contro Rel. Bioact.Mater. 16 (1989) pp 22-23.
24. Chan HK, Clark A, Gonda I, Mumenthaler M, Hsu C. "Spray dried powders for recombinant human deoxyribonuclease (rh Dnase) for aerosol delivery" Pharm Res. 14 (1997) pp 431-437.
25. Maa YF, Nguyen PAT, Hsu SW. "Spray-drying of air-liquid interface sensitive recombinant human growth harmone" J. Pharm. Sci. 87(2) (1998, pp152-159
26. Broadhead J, Rouan SKE, Hau I, Rhodes CT "The effect of process and formulation variables on the properties of spray dried beta-galactosidase" J Pharm Pharmacol. 46(6) (1994, pp458-467
27. Maa YF, Nguyen PA, Sweeny T, Shire SJ, HsuCC. "Protein Inhalation Powders: Spray Drying vs. Spray freeze Drying " Pharm Res. 16: 2 (1999) pp 249-254
28. Sevelle PC, KellayLW, Birchall JC. "Prepartion of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying" J. Gene Med. 4 (2002) pp 428-437
29. Parikh DM, Erkoboni D. " Spray Drying" presented at Annual AAPS meeting , 2000.
30. Martino PD, Scoppa M, Joiris E, Palmieri G, Andres C, Pourcelo Y, Martelli S. "The spray drying of acetazolamide as method to modify crystal properties and to improve compression behavior" Int. J. Pharmaceutics 213 (2001) pp 209-221
31. Rattes ALR, Oliveria WP. "Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles" Pow. Tech. 17 (2007) pp 7-14
32. Orienti I, Cerchiara T, Luppi B, Bigucci F, Zuccari G, Zecchi V. "Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery" Int. J. Pharmaceutics 238 (2002) pp 51-59
33. Esposito E, Cervellati F, Menegatti E, Nastruzzi C, Cortesi R. " Spray dried Eudragit microprticles as encapsulation devices for vitamin C. " Int. J. Pharmaceutics 242 (2002) pp 329-334
34. Kim JC, Lee HY, Kim MH, Lee HJ, Kang HY, Kim SM. " Prepartion and charctrization of chitosan/gelatin microcapsules containing triclosan" Colloids and surface Biointerfaces 52 (2006) pp 52-56
35. Vergote GJ, Vervaet C, Driessche IV, Hoste S, DeSmedt S, Demeester J, Jain RA, Ruddy S, Remon JP. " An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen" Int. J. Pharmaceutics, 219 (2001) pp 81-87
36. Billon A, Bataille B, Cassanas G, Jacob M. "Development of spraydried acetaminophen microparticles using experimental designs" Int. J. Pharmaceutics 203 (2000) pp 159-168
37. Mladenovska K, Cruaud O, Richomme P, Belamie E, Raicki RS, Venier-Julienne MC, Popvski E, Benoit JP, Goracinova K. " 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization" Int. J. Pharmaceutics 345 (2007) pp 59-69
38. Takashima Y, Saito R, Namajima A, Oda M, Kimura A, Kanazawa T, Okada H. " Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres" Int. J. Pharmaceutics, 343 (2007) pp 262-269.